| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/2005 | EP1015014A4 Methods and compositions for inhibiting angiogenesis |
| 01/05/2005 | EP0996619B1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/05/2005 | EP0912196B9 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 01/05/2005 | EP0837930B1 A TRP-226 MUTANT HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 01/05/2005 | EP0730609B1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 01/05/2005 | EP0699078B1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | DE10329839A1 Use of artificial nutrition solutions to treat skin diseases, especially psoriasis, neurodermatitis, acne, dermatoses or eczema |
| 01/05/2005 | DE10326821A1 Pharmazeutische Kombinationspräparate zur Krebstherapie Pharmaceutical combination preparations for cancer therapy |
| 01/05/2005 | CN1561394A Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 01/05/2005 | CN1561391A Recombinant bacterial phytases and uses thereof |
| 01/05/2005 | CN1561390A PEG-modified uricase |
| 01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 01/05/2005 | CN1561343A Soluble T cell receptor |
| 01/05/2005 | CN1561235A Device having osteoinductive and osteoconductive properties |
| 01/05/2005 | CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin |
| 01/05/2005 | CN1561231A Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561228A Enhancing organ maturity in neonates and predicting their duration of intensive care |
| 01/05/2005 | CN1561227A Method for treating hepatitis C virus infection in treatment failure patients |
| 01/05/2005 | CN1561226A Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 01/05/2005 | CN1561225A Modulation of leukocyte-endothelial interactions following ischemia |
| 01/05/2005 | CN1561224A A method of reducing mortality and morbidity associated with critical illnesses |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1561218A Enteral compositions for the prevention and/or treatment of sepsis |
| 01/05/2005 | CN1561208A Methods to mobilize progenitor/stem cells |
| 01/05/2005 | CN1561197A Method for producing biologically active products |
| 01/05/2005 | CN1561164A 抗微生物剂 Antimicrobial agent |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560241A Mutant of recombined glucokinase for anti blood platelet collecting and low immunogencity |
| 01/05/2005 | CN1560080A Corpuscles of stannius protein, stanniocalcin |
| 01/05/2005 | CN1560078A Tumor antigen based on products of the tumor suppressor gene WT1 |
| 01/05/2005 | CN1560076A Derivant with reducing calcium gene related peptide and preparation process thereof |
| 01/05/2005 | CN1560074A Polypeptide of inhibiting crown virus and its derivant |
| 01/05/2005 | CN1560073A Analogy short peptide at growth factor antigen surface position of basicity fibroblast and its sieving and using |
| 01/05/2005 | CN1560066A Recombined immune toxin protein of anticryptic sporozoan and its preparation process and medical application |
| 01/05/2005 | CN1559609A Spirit relieving drink and its preparation method |
| 01/05/2005 | CN1559608A Applicaton of alpha interferon in external used medicine for treating eczema |
| 01/05/2005 | CN1559606A Cyclosporin A dispersion solid and its preparation method |
| 01/05/2005 | CN1559605A Compound aloe health-care tablet |
| 01/05/2005 | CN1559444A Oral liquid contg. extration of sturgeon and sturgeon active protein capsule, prepn. method therefor |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183158C Exendin analogue, processes for their preparation and medicaments containing them |
| 01/05/2005 | CN1183156C Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 01/05/2005 | CN1183112C PEG-inerferon conjugate |
| 01/05/2005 | CN1182879C Stabilized mixture comprising fibrinogen |
| 01/05/2005 | CN1182874C Gene therapy for diabetic ischemic disease |
| 01/05/2005 | CN1182870C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 01/05/2005 | CN1182869C Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
| 01/05/2005 | CN1182868C Mutent enterotoxin effective as non-toxic oral adjuvant |
| 01/05/2005 | CN1182842C Soft gelatin capsule and its manufacture method |
| 01/05/2005 | CN1182832C Composition for making unstable material of oxygen stabilize |
| 01/04/2005 | US6838549 For treatment of leukemia; enhancing bone marrow recovery in allogeneic or autologous transplantation and in treatment, radiation, chemically, or chemotherapeutically induced aplasia or myelosuppression |
| 01/04/2005 | US6838548 Artiodactyl epimorphine |
| 01/04/2005 | US6838547 Acryloyl derivatives of distamycin conjugated with glutathione; have antitumor activity and are thus useful in therapy in the treatment of cancer |
| 01/04/2005 | US6838528 Absorption, bioavailability |
| 01/04/2005 | US6838475 For prophylaxis and therapy of one or more symptoms of hepatitis C |
| 01/04/2005 | US6838455 Inhibiting beta -amyloid peptide release and/or its synthesis in a cell by administering deoxyamino acid compound |
| 01/04/2005 | US6838449 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/04/2005 | US6838446 Anticancer agents; genetic engineered enzyme |
| 01/04/2005 | US6838445 Tumor antigen peptide originating in SART-1 |
| 01/04/2005 | US6838444 Using nucleic acid; repair interior ear hair |
| 01/04/2005 | US6838441 Respiratory system diosrders in infants; administering albumin; blocking bile acids |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838438 Motilin Homologs |
| 01/04/2005 | US6838437 Inactivation resistant factor VIII |
| 01/04/2005 | US6838436 Osteoporosis, bone fractures, oral diseases; administering a protein |
| 01/04/2005 | US6838435 Grampositive, gramnegative bacteria; bactericides, fungicides; antibiotic resistance |
| 01/04/2005 | US6838434 Methods for treating sinus headache |
| 01/04/2005 | US6838433 Peptides used as inhibitors of interleukin-6 (IL-6), for prophylaxis, therapy and/or diagnosis of blood disorders such as leukemia |
| 01/04/2005 | US6838432 Treatment of sepsis with TAFI |
| 01/04/2005 | US6838431 Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety |
| 01/04/2005 | US6838430 Use of HIF-1a variants to accelerate wound healing |
| 01/04/2005 | US6838429 Atopic dermatitis treatment method |
| 01/04/2005 | US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase |
| 01/04/2005 | US6838290 Detecting modulators of interleukin activity; obtain modulator, incubate with preferential cells, monitor interleukin response |
| 01/04/2005 | US6838283 Antitumor agents |
| 01/04/2005 | US6838282 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy |
| 01/04/2005 | US6838281 Cells expressing fusion proteins of immunoglobulins |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838269 Comprises reduced allergenic variant of enzymatic polypeptide for use in textile treatment and cleaning composition and animal feeds; antiallergens |
| 01/04/2005 | US6838262 Isolated DNA molecule encoding rank ligand |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/04/2005 | US6838258 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 01/04/2005 | US6838252 Inhibitors of proteasomal activity for stimulating hair growth |
| 01/04/2005 | US6838245 Enzymatic polypeptide for use in the treatment of cell proliferation, inflammatory, and immune response defects |
| 01/04/2005 | US6838241 Protein transport-associated molecules |
| 01/04/2005 | US6838237 Antigenically reactive regions of the hepatitis a virus polyprotein |
| 01/04/2005 | US6838236 Comprises human immunodeficiency virus viral protein r (VPR) for treating and preventing cancer and viral diseases |
| 01/04/2005 | US6838113 Increasing the digestibility of food proteins by thioredoxin reduction |
| 01/04/2005 | US6838096 Black soybean polysaccharides |
| 01/04/2005 | US6838093 System for osmotic delivery of pharmaceutically active agents |
| 01/04/2005 | US6838084 For connection with major histomcompatability complex molecules |
| 01/04/2005 | US6838081 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient |
| 01/04/2005 | US6838079 Methods for using the obese product to stimulate hematopoietic development |
| 01/04/2005 | US6838076 Pulmonary administration of chemically modified insulin |
| 01/04/2005 | US6838075 For aerosolized delivery to lungs |
| 01/04/2005 | US6837184 Programmable electronic maze for use in the assessment of animal behavior |
| 01/04/2005 | CA2432972A1 Sushi peptides, processes for making and uses thereof |